期刊文献+

一种检测帕金森患者血浆促进α-突触核蛋白寡聚体形成能力的方法 被引量:6

A method for evaluation of α-synuclein oligomer formation in plasma of patients with Parkinson's disease
下载PDF
导出
摘要 目的建立一种检测帕金森病(Parkinson’s disease,PD)患者血浆促进外源性α-突触核蛋白(α-synuclein,α-Syn)寡聚体形成的方法。方法利用本室自制的鼠抗人α-Syn单克隆抗体建立检测α-Syn寡聚体的酶联免疫吸附测定(enzyme linked immunosorbent,ELISA)方法。将不同质量浓度(200、100、50、25、12.5μmol/L)重组人α-Syn在正常人和PD患者血浆中分别振荡孵育(37℃、280 r/min)24、48、72、96 h。用所建立的ELISA法检测振荡后血浆中的α-Syn寡聚体含量。结果所建立ELISA方法可以特异性检测α-Syn寡聚体,不识别α-Syn单体。重组人α-Syn在质量浓度为100μmol/L、血浆稀释3倍以下、振荡孵育48h条件下可以在PD患者血浆中形成较多的寡聚体,并与对照血浆中形成的α-Syn寡聚体含量对比差异最大。结论成功建立了一种检测PD患者血浆促进α-Syn寡聚体形成能力的方法,该方法可以用于诊断PD患者血浆的潜在病理变化。 Objective To establish a method for evaluation of exogenous α-synuclein (α-Syn) oligomer formation in plasma of patients with Parkinson' s disease(PD). Methods An ELISA method was developed by using the 3D5 mouse anti-human a-Syn monoclonal antibody. Various concentrations of α-Syn(200, 100, 50, 25, 12.5 μmol/L) was incubated(37℃ , 280 r/min) in PD and control sera for 24, 48, 72, and 96 h. The amounts of α-Syn oligomers formed in the sera were measured using the established ELISA method. Results The ELISA method established specifically detected α-Syn oligmers with no reaction to α-Syn monomers. The best differentiation between the α-Syn oligomer formation in PD and control sera was observed when the recombinant α-Syn concentration was 100 μmol/L, with the incubation time being 48 h and the plasma diluted to less than 1/3. Conclusion A method for evaluation of α-Syn oligomer formation in the sera of PD patients and normal controls was established, which can differentiate the potential pathological changes of PD.
出处 《首都医科大学学报》 CAS 2013年第6期830-834,共5页 Journal of Capital Medical University
基金 国家自然科学基金(81071014) 国家重点基础研究发展计划(2011CB504101) 首都卫生发展科研专项课题(首发2011-1001-01) 国家科技支撑计划课题(2012BAI10B03) 北京市自然科学基金(7102076)~~
关键词 帕金森病 Α-突触核蛋白 血浆 寡聚体 Parkinson' s disease α-synuclein plasma oligomer
  • 相关文献

参考文献12

  • 1George S,Rey N L,Reichenbach N. α-Synuclein:the long distance runner[J].{H}Brain Pathology,2013,(03):350-357. 被引量:1
  • 2Jellinger K A. Critical evaluation of the Braak staging scheme for Parkinson's disease[J].{H}Annals of Neurology,2010,(04):550. 被引量:1
  • 3Spillantini M G,Schmidt M L,Lee V M. Alpha-synuclein in Lewy bodies[J].{H}NATURE,1997,(6645):839-840. 被引量:1
  • 4Baba M,Nakajo S,Tu P H. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies[J].{H}AMERICAN JOURNAL OF PATHOLOGY,1998,(04):879-884. 被引量:1
  • 5Ferrer I,Martinez A,Blanco R. Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism:preclinical Parkinson disease[J].{H}Journal of Neural Transmission,2011,(05):821-839. 被引量:1
  • 6Sulzer D,Surmeier D J. Neuronal vulnerability,pathogenesis,and Parkinson's disease[J].{H}Movement Disorders,2013,(01):41-50. 被引量:1
  • 7Kalia L V,Kalia S K,McLean P J. α-Synuclein oligomers and clinical implications for Parkinson disease[J].{H}Annals of Neurology,2013,(02):155-169. 被引量:1
  • 8Danzer K M,McLean P J. Drug targets from genetics:alpha-synuclein[J].CNS Neurol Disord Drug Targets,. 被引量:1
  • 9Park M J,Cheon S M,Bae H R. Elevated levels of α-synuclein oligomer in the cerebrospinal fluid of drug-nave patients with Parkinson's disease[J].{H}J Clin Neurology,2011,(04):215-222. 被引量:1
  • 10El-Agnaf O M,Salem S A,Paleologou K E. Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson's disease[J].{H}FASEB JOURNAL,2006,(03):419-425. 被引量:1

二级参考文献11

  • 1Mizuno Y,Hattori N,Kubo S,et al.Progress in the pathogenesis and genetics of Parkinson's disease[J].Philos Trans R Soc Lond B Biol Sci,2008,363:2215-2227. 被引量:1
  • 2Lees A J,Hardy J,Revesz T.Parkinson's disease[J].Lancet,2009,373:2055-2066. 被引量:1
  • 3Liu G W,Zhang C Y,Yin J J,et al.α-Synuclein is differentially expressed in mitochondria from different rat brain regions and dose-dependently down-regulates complex I activity[J].Neurosci Lett,2009,454:187-552. 被引量:1
  • 4Devi L,Raghavendran V,Prabhu B M,et al.Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson' disease brain[J].J Biol Chem,2008,283:9089-9100. 被引量:1
  • 5Loeb V,Yakunin E,Saada A,et al.The transgenic overexpression of alpha-synuclein and not its related pathology associates with complex I inhibition[J].J Biol Chem,2010,285:7334-7343. 被引量:1
  • 6Henchcliffe C,Beal M F.Mitochondrial biology and oxidative stress in Parkinson' disease pathogenesis[J].Nat Clin Pract Neurol,2008,4:600-609. 被引量:1
  • 7Seet R C,Lee C Y,Lim E C,et al.Oxidative damage in Parkinson disease:measurement using accurate biomarkers[J].Free Radic Biol Med,2010,48:560-566. 被引量:1
  • 8Yu S,Uéda K,Chan P.Alpha-synuclein and dopamine metabolism[J].Mol Neurobiol,2005,31:243-254. 被引量:1
  • 9Goers J,Manning-og A B,McCormack A L,et al.Nuclear localization of alpha-ynuclein and its interaction with histones[J].Biochemistry,2003,42:8465-8471. 被引量:1
  • 10Baptista M J,O'Farrell C,Daya S,et al.Co-rdinate transcriptional regulation of dopamine synthesis genes by alpha-ynuclein in human neuroblastoma cell lines[J].J Neurochem,2003,85:957-968. 被引量:1

共引文献6

同被引文献26

  • 1Abbott R D,Petrovitch H,White L R,et al.Frequency of bowel movements and the future risk of Parkinson' s disease[J] .Neurology,2001,57 (3):456-462. 被引量:1
  • 2Claassen D O,Josephs K A,Ahlskog J E,et al.REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century[J] .Neurology,2010,75 (6):494-499. 被引量:1
  • 3Liu Y,Qiang M,Wei Y,et al.A novel molecular mechanism for nitrated α-synuclein-induced cell death[J] .J Mol Cell Biol,2011,3 (4):239-249. 被引量:1
  • 4Fujiwara H,Hasegawa M,Dohmae N,et al.α-Synuclein is phosphorylated in synucleinopathy lesions[J] .Nat Cell Biol,2002,4 (2):160-164. 被引量:1
  • 5Mbefo M K,Paleologou K E,Boucharaba A,et al.Phosphorylation of α-synucleins by members of the Polo-like kinase family[J] .J Biol Chem,2010,285 (4):2807-2822. 被引量:1
  • 6Giasson B I,Duda J E,Murray I V,et al.Oxidative damage linked to neurodegeneration by selective α-synuclein nitration in synucleinopathy lesions[J] .Science,2000,290(5493):985-989. 被引量:1
  • 7Hodara R,Norris E H,Giasson B I,et al.Functional consequences of α-synuclein tyrosine nitration:diminished binding to lipid vesicles and increased fibril formation[J] .J Biol Chem,2004,279 (46):47746-47753. 被引量:1
  • 8Paleologou K E,Schmid A W,Rospigliosi C C,et al.Phosphorylation at Ser-129 but not the phosphomimics S129E/D inhibits the fibrillation of α-synuclein[J] .J Biol Chem,2008,283 (24):16895-16905. 被引量:1
  • 9Kirkitadze M D,Bitan G,Teplow D B.Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders:the emerging role of oligomeric assemblies[J] .J Neurosci Res,2002,69 (5):567-577. 被引量:1
  • 10Yu S,Li X,Liu G,et al.Extensive nuclear localization of alpha-synuclein in normal rat brain neurons revealed by a novel monoclonal antibody[J] .Neuroscience,2007,145(2):539-555. 被引量:1

引证文献6

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部